There exists a variety of anti-diabetic agents which reduce insulin resistance (metformin, thiazolidinediones), increase insulin secretion (sulfonylureas, DPP 4 inhibitors, incretin mimetics), or release glucose from the urine (sodium/glucose cotransporter 2 inhibitors)3. Here, INS is linked to Insulin resistance.